Sherrie Pietranico-Cole
Roche (Switzerland)(CH)La Roche College(US)
Publications by Year
Research Areas
Drug Transport and Resistance Mechanisms, Diabetes Treatment and Management, Hormonal Regulation and Hypertension, Heart Failure Treatment and Management, Thyroid Disorders and Treatments
Most-Cited Works
- → Discovery of 2-[3,5-Dichloro-4-(5-isopropyl-6-oxo-1,6-dihydropyridazin-3-yloxy)phenyl]-3,5-dioxo-2,3,4,5-tetrahydro[1,2,4]triazine-6-carbonitrile (MGL-3196), a Highly Selective Thyroid Hormone Receptor β Agonist in Clinical Trials for the Treatment of Dyslipidemia(2014)208 cited
- → Modulation of Receptor and Receptor Subtype Affinities Using Diastereomeric and Enantiomeric Monosaccharide Scaffolds as a Means to Structural and Biological Diversity. A New Route to Ether Synthesis(1998)108 cited
- → 2‐Phenoxy‐nicotinamides are Potent Agonists at the Bile Acid Receptor GPBAR1 (TGR5)(2012)40 cited
- → Discovery of pyrazolo[3,4-d]pyrimidine derivatives as GPR119 agonists(2013)13 cited
- → A Transgenic Platform for Testing Drugs Intended for Reversal of Cardiac Remodeling Identifies a Novel 11βHSD1 Inhibitor Rescuing Hypertrophy Independently of Re-Vascularization(2014)7 cited
- → Discovery of camphor-derived pyrazolones as 11β-hydroxysteroid dehydrogenase type 1 inhibitors(2014)2 cited
- → Cover Picture: 2‐Phenoxy‐nicotinamides are Potent Agonists at the Bile Acid Receptor GPBAR1 (TGR5) (ChemMedChem 4/2013)(2013)